16 employees
Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs.
2020
Westlake Omics 西湖欧米 raised undisclosed on January 13, 2022
Investors: Med-Fine Capital and Hillhouse Capital Management